Enveric Biosciences, Inc.
(NASDAQ : AMRH)

( )
AMRH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.82%27.9314.1%$164.34m
ICLRICON plc -0.61%224.274.2%$149.09m
JAZZJazz Pharmaceuticals Plc 1.21%175.902.2%$133.34m
HZNPHorizon Therapeutics Plc -0.96%86.565.5%$116.43m
CTLTCatalent, Inc. -2.34%101.572.1%$105.74m
BHCBausch Health Cos., Inc. 1.82%27.930.0%$88.73m
SAVACassava Sciences, Inc. -4.44%37.490.0%$55.76m
UTHRUnited Therapeutics Corp. 0.61%195.4914.0%$55.68m
PRGOPerrigo Co. Plc 3.29%45.806.9%$44.37m
BLRXBioLineRx Ltd. -7.60%2.920.8%$39.46m
ARGXargenx SE 0.37%258.210.0%$38.07m
SAGESAGE Therapeutics, Inc. -0.38%73.887.6%$35.36m
PCRXPacira Biosciences, Inc. 2.08%61.989.9%$26.35m
AXSMAxsome Therapeutics, Inc. -0.04%57.011.9%$26.03m
RVMDRevolution Medicines, Inc. 0.00%31.650.0%$24.96m

Company Profile

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.